Conference Calls & Webcasts

Latest Webcast

05/03/2013 - Conference Call and Webcast: Q1 2013 Results

MorphoSys AG published its first three months’ 2013 results on May 3, 2013.

During a public conference call and webcast, the Management Board of MorphoSys AG presented MorphoSys’s financial results for the first three months of 2013 and provided further details on the Company’s latest developments.

Replay of the Q1 2013 Webcast

Archive

05/25/2011 - Webcast: UBS Global Specialty Pharmaceuticals Conference 2011

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the UBS Global Specialty Pharmaceuticals Conference 2011, in London, UK, on Wednesday, May 25, 2011.

Go to Webcast...

06/06/2011 - Webcast: Jefferies 2011 Global Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, and Jens Holstein, CFO of MorphoSys AG, presented the Company at the Jefferies 2011 Global Healthcare Conference in New York, USA, on June 06, 2011.

Go to Webcast...

03/17/2011 - Webcast: Barclays Global Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the Barclays Global Healthcare Conference in Miami, FL, on Thursday, March 17, 2011.

Go to Webcast...

02/24/2011 - Year-end 2010 and Q4 Results

MorphoSys published its Annual Financial Results 2010 on February 24, 2011. In conjunction with that, the Company held a conference call to further discuss the financial and operational results.

Annual Report 2010 (Online Version)

01/12/2011 - Webcast: J.P. Morgan Healthcare Conference

Dr. Simon Moroney, CEO of MorphoSys AG, presented the Company at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 12, 2011 at 07:30am PST (03:30pm GMT; 04:30pm CET).

Go to Webcast...

11/29/2010 - R&D Day, New York

MorphoSys AG will host an R&D day in November to give an update on its partnered pipeline, proprietary portfolio and recent technology developments.

Download Presentations

Introduction

Technology Update

Update Partnered Pipeline

Proprietary Development

GM-CSF: A central mediator in inflammation

MOR103
 
MOR202

MOR208 - Dr. John Desjarlais

MOR208 - Dr. Lisa Rojkjaer

Closing Remarks

Complete Presentation

11/25/2010 - R&D Day, London

MorphoSys AG will host an R&D day in November to give an update on its partnered pipeline, proprietary portfolio and recent technology developments.

Download Presentations

Introduction

Technology Update

Update Partnered Pipeline

Proprietary Development

GM-CSF: A central mediator in inflammation

MOR103
 
MOR208
 
MOR202

Closing Remarks

Complete Presentation